List of Voquezna Triple Pak drug patents

Voquezna Triple Pak is owned by Phathom.

Voquezna Triple Pak contains Amoxicillin; Clarithromycin; Vonoprazan Fumarate.

Voquezna Triple Pak has a total of 2 drug patents out of which 0 drug patents have expired.

Voquezna Triple Pak was authorised for market use on 03 May, 2022.

Voquezna Triple Pak is available in capsule, tablet, tablet;oral dosage forms.

Drug patent challenges can be filed against Voquezna Triple Pak from 2031-05-04.

The generics of Voquezna Triple Pak are possible to be released after 03 May, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7977488 PHATHOM 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
Aug, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9186411 PHATHOM Pharmaceutical composition
Aug, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) May 3, 2027
Generating Antibiotic Incentives Now (GAIN) May 3, 2032

Drugs and Companies using AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE ingredient

NCE-1 date: 2031-05-04

Market Authorisation Date: 03 May, 2022

Treatment: NA

Dosage: CAPSULE, TABLET, TABLET;ORAL

More Information on Dosage

VOQUEZNA TRIPLE PAK family patents

11

United States

11

Japan

5

Peru

4

Spain

4

China

4

European Union

3

Argentina

3

Brazil

3

Korea, Republic of

3

Taiwan, Province of China

3

Georgia

3

Canada

3

New Zealand

2

South Africa

2

Denmark

2

Australia

2

Hong Kong

2

Slovenia

2

Morocco

2

Costa Rica

2

Croatia

2

Portugal

2

Cyprus

2

Malaysia

2

Dominican Republic

2

Poland

2

Chile

2

RS

2

Ukraine

EA

2

EA

1

Israel

1

Austria

1

Mexico

1

Jordan

1

Russia

1

Uruguay

1

Norway

1

Germany

1

Colombia

1

Singapore

1

Ecuador

1

Tunisia

1

ME

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in